Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus
- PMID: 7924757
- DOI: 10.1159/000457546
Effect of indomethacin on cerebral blood flow velocities in very low birth weight neonates with a patent ductus arteriosus
Abstract
The effect of repeated doses of indomethacin on mean peak velocity (MPV) and time-averaged mean velocity in the middle cerebral artery was assessed in 10 ventilated neonates with a patent ductus arteriosus using colour/duplex Doppler technique prior to, and 10, 30, and 120 min after the first and the third dose. Velocities were significantly reduced up to 120 min after the first dose. The third dose resulted in a significant reduction in MPV at 10 and 30 min following treatment. This reduction was half of that observed after the first dose. Systemic blood pressure (BP) and heart rate did not change significantly after each separate dose. However, by the third dose, mean and diastolic BP were significantly increased from pretreatment levels. The attenuated response of cerebral blood flow (CBF) velocities to the third dose of indomethacin compared with the first dose is probably related to altered haemodynamics. Indomethacin should be used cautiously in infants with other conditions which are known to decrease CBF such as hypotension, hypocarbia and polycythaemia.
Similar articles
-
Regional cerebral blood flow velocity changes after indomethacin infusion in preterm infants.Arch Dis Child. 1992 Jul;67(7 Spec No):851-4. doi: 10.1136/adc.67.7_spec_no.851. Arch Dis Child. 1992. PMID: 1519988 Free PMC article.
-
Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: duration of its effect.Pediatrics. 1989 Nov;84(5):802-7. Pediatrics. 1989. PMID: 2677960
-
A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity.Eur J Pediatr. 1999 Jun;158(6):484-7. doi: 10.1007/s004310051125. Eur J Pediatr. 1999. PMID: 10378397
-
The effect of indomethacin on cerebral blood-flow velocity in premature infants.Dev Med Child Neurol. 1987 Dec;29(6):776-82. doi: 10.1111/j.1469-8749.1987.tb08823.x. Dev Med Child Neurol. 1987. PMID: 3691977
-
[Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].Med Wieku Rozwoj. 2000;4(2 Suppl 3):65-71. Med Wieku Rozwoj. 2000. PMID: 11328971 Review. Polish.
Cited by
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
-
Patent arterial duct.Orphanet J Rare Dis. 2009 Jul 10;4:17. doi: 10.1186/1750-1172-4-17. Orphanet J Rare Dis. 2009. PMID: 19591690 Free PMC article. Review.
-
Prophylactic cyclo-oxygenase inhibitor drugs for the prevention of morbidity and mortality in preterm infants: a network meta-analysis.Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013846. doi: 10.1002/14651858.CD013846.pub2. Cochrane Database Syst Rev. 2022. PMID: 35363893 Free PMC article.
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2018 Sep 28;9(9):CD003481. doi: 10.1002/14651858.CD003481.pub7. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Feb 11;2:CD003481. doi: 10.1002/14651858.CD003481.pub8. PMID: 30264852 Free PMC article. Updated.
-
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.Cochrane Database Syst Rev. 2019 Jun 21;6(6):CD004213. doi: 10.1002/14651858.CD004213.pub4. Cochrane Database Syst Rev. 2019. Update in: Cochrane Database Syst Rev. 2020 Jan 27;1:CD004213. doi: 10.1002/14651858.CD004213.pub5. PMID: 31222841 Free PMC article. Updated.